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The sharing of scientific, genomic and health-related data
for the purpose of research is of key importance in en-
suring continued progress in our understanding of human
health and wellbeing. New challenges raised by inter-
national, collaborative research require a principled and
practical framework that brings together researchers, reg-
ulators, funders, patient groups, information technologists,
and consortia to share data. Such a framework will facili-
tate global science and responsible research conduct.
This International Code of Conduct provides guidance
for the responsible sharing of genomic and health-
related data. In particular, it is guided by Article 27 of
the 1948 Universal Declaration of Human Rights. Article
27 guarantees the rights of every individual in the world
“to share in scientific advancement and its benefits”, to
freely engage in responsible scientific inquiry, and at the
same time “to the protection of the moral and material
interests resulting from any scientific…production of
which [a person] is the author.” Article 27 has been ex-
panded by other enforceable international conventions
and national laws, regulations, codes and policies set out
in Appendix 1.
This Code establishes a set of foundational principles and
guidelines for responsible research conduct and oversight
of research data systems, guided by the enforceable human
rights of privacy, non-discrimination, and procedural fair-
ness. The Code also: (a) interprets the right to enjoy the
benefits of scientific progress and its applications as being
the right to engage in responsible scientific inquiry, access
and share genomic and health-related data across the
translation continuum, from basic research through prac-
tical applications; and (b) applies the right to benefit from
the protection of the moral and material interests resulting
from scientific productions to health-related research by
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in any medium, provided the original work is pThe value of this Code is that it: offers political and legal
dimensions that reach beyond the moral appeals of bioeth-
ics and provides a more robust governance framework for
genomic and health-related data sharing; speaks to groups
and institutions, not just individuals; stresses the progres-
sive realization of duties, urging action by governments,
industry, funders, and researchers to create an environ-
ment for responsibly sharing data; and fosters responsible
research in health by offering stronger protection in crit-
ical areas.
Purpose and interpretation
The purpose of this Code is to provide a principled and
practical framework for the sharing of genomic and health-
related data. This Code should be interpreted in good faith.
This Code is to be understood as a whole and the Foun-
dational Principles and Guidelines are to be understood
as complementary and interrelated. Each Foundational
Principle and Guideline is to be considered in the context
of the other Foundational Principles and Guidelines, as ap-
propriate and relevant in the circumstances.
The primary goals of this Code are to:
1.1. Protect and promote the welfare, rights, and
interests of groups and individuals who provide
their data;
1.2. Provide guidance and benchmarks for
accountability;
1.3. Complement laws and regulations on privacy and
data protection, as well as codes for the ethical
governance of research;
1.4. Foster responsible data sharing and oversight of
research data systems;
1.5. Establish a framework for greater international data
sharing cooperation, collaboration, and good
governance;
1.6. Serve as a dynamic instrument that can grow and
change in response to future developments in the
science and practices of genomic and health-related
data sharing; andpen Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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ethics committees.Application
This Code may be adopted and implemented by organiza-
tions and bodies involved in genomic and health related
data sharing.
This Code applies to:
2.1. Researchers, research participant and patient
communities;
2.2. Research organizations;
2.3. Universities, colleges and research institutes;
2.4. National and regional research ethics and other
government bodies;
2.5. Research ethics committees and data access
committees;
2.6. Clinics, hospitals, health care centers and institutes;
2.7. Research funding agencies;
2.8. Professional research organizations;
2.9. Industry;
2.10. Information technologists and research data
system providers; and
2.11.Other bodies or individuals requesting, accessing,
managing or otherwise using genomic and
health-related data.Foundational principles
The Foundational Principles of this Code guide responsible
data sharing. They also facilitate compliance with the obli-
gations set by international and national law and policies.Foundational principles for responsible data sharing
 Promote Health and Wellbeing.
 Respect Individuals, Families and Communities.
 Advance Research and the Fair Distribution of
Benefits.
 Foster Trust, Integrity and Reciprocity.Guidelines and core elements
These Guidelines include core elements that aim to prac-
tically apply the Foundational Principles to individuals and
organizations involved in the sharing of genomic and
health-related data. The Guidelines should be interpreted
in a proportionate manner that acknowledges different
levels of risk and community cultural practices. This Code
applies to data that has been consented to for use and/or
approved therefor by competent authorities. Adherence to
the Guidelines does not preclude further consideration
and development of additional elements.Guidelines and core elements for responsible data
sharing
1. Transparency
1.1. Developing clearly defined and accessible
information on the purposes, processes, procedures
and governance frameworks for data sharing.
1.2. Providing information on the purpose,
collection, use and exchange of genomic and
health-related data, including: data transfer to
third parties, international transfer of data, terms
of access, re-identifiability and limits to anonym-
ity or confidentiality of data, return of results,
commercial involvement, and proprietary claims.
1.3. Implementing procedures for fairly adjudicating
requests for data access and exchange.2. Accountability
2.1. Putting in place systems for data sharing that are
compliant with this Code and for tracking the
chain of data exchange.
2.2. Identifying processes to identify and manage
conflicts of interest.
2.3. Implementing mechanisms for handling
complaints and enforcing this Code, and
identifying and managing breaches of the Code.3. Data Security and Quality
3.1. Storing and processing the data collected, used
and transferred that is accurate, verifiable,
unbiased, and current, so as to enhance their
interoperability and replicability while preserving
their long-term searchability and integrity.
3.2. Ensuring feedback mechanisms on the utility,
quality, security, value, consistency and
annotations on data, with a view to improving
their quality and interoperability and re-use by
others.
3.3. Installing strict data security measures to prevent
unauthorized access, data loss and misuse, and to
ensure that all users in the chain of data exchange
are in compliance with these measures.4. Privacy, Data Protection and Confidentiality
4.1. Complying with applicable privacy and data
protection regulations, along with assurances
that confidentiality and privacy are appropriately
protected when data are collected, used and
exchanged. Depending on the nature of the data,
different levels of privacy and data protection
may be necessary.
4.2. Informing individuals, families and communities
about the use and exchange of data relating to
them, depending on the nature of the data.
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5.1. Conducting data sharing with a view towards
minimizing harms and maximizing benefits to
not just those who contribute their data, but
also to society and health care systems as a
whole, particularly where data pertains to people
based in more disadvantaged parts of the world.
5.2. Considering the realistic harms and benefits of
data sharing on individuals, families and
communities, including opportunity costs.
5.3. Undertaking a proportionate assessment of the
benefits and risks of harm in data sharing, which
is periodically monitored according to the
reasonable foreseeability of such harms and
benefits.6. Recognition and Attribution
6.1. Designing systems of data sharing with a view
towards recognition and attribution that are
meaningful and appropriate to the medium or
discipline concerned and which provide due
credit and acknowledgement of all who
contributed to the results.
6.2. Extending recognition and attribution equally to
secondary or downstream uses and applications.
All parties should act in good faith to ensure
that the connections to original sources of data
are maintained in the public record to the extent
permissible by law.7. Sustainability
7.1. Addressing projects and systems for sharing
genomic and health-related data at the earliest
stage so as to ensure the sustainability of the
data generated for future use, including their
archiving and identifiability.8. Accessibility and Dissemination
8.1. Ensuring accessibility of data for approved
research and data sharing purposes.
8.2. Promoting collaborative partnerships and data
sharing that can generate maximum value, along
with the harmonization of deposit, management
and access procedures and use as a means to
promote accessibility.
8.3. Publishing and disseminating research results,
both positive and negative, depending on the
nature of the data. Dissemination of research
results should be conducted in a way that
promotes broad access and minimizes obstacles
to data sharing.
8.4.Making data and research results widely
available in a manner that promotes scientific
collaboration and reproducibility.Implementation mechanisms and amendments
5.1. Persons and entities listed in section 2 of this Code
should take all appropriate measures, whether of a
legislative, administrative or other character, to give
effect to the Foundational Principles and Guidelines
set out in this Code in accordance with the
international law of human rights and should, by
means of all appropriate measures, promote their
implementation.
5.2. Any persons and entity listed in section 2 of this
Code may propose one or more amendments to
the present Code by communicating the
amendments to the Regulatory and Ethics Working
Group of the Global Alliance for Genomics and
Health (the ‘REWG’). The Regulatory and Ethics
Working Group shall publicly circulate such
amendments for comments and eventual adoption.
5.3. The REWG, in collaboration with biomedical,
patient advocacy, and ethical and policy
organizations and committees, will track the
application of this Code, and routinely review its
provisions in order to keep the Code continuously
up-to-date with new advances in basic research and
technology, as well as ethical and legal
developments.
Appendix 1
Foundational human rights instruments
*Universal Declaration of Human Rights (UN 1948)
(Article 27)
*International Covenant on Economic, Social and Cultural
Rights (UN 1966) (Article 15)
Ethical and legal codes and policies guiding data sharing
behavior
 Constitution of the World Health Organization
(WHO 1946)
 Bermuda Principles on Human Genome
Sequencing (1996)
 Universal Declaration on the Human Genome and
Human Rights (UNESCO 1997)
 The Convention on Human Rights and
Biomedicine (Council of Europe 1997)
 Statement on DNA Sampling: Control and Access
(HUGO 1998)
 Statement on Human Genomic Databases (HUGO
Ethics Committee 2002)
 Declaration of Ethical Considerations regarding
Health Databases (WMA 2002)
 International Ethical Guidelines for Biomedical
Research Involving Human Subjects (CIOMS,
WHO 2002)
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 Sharing Data from Large-scale Biological Research
Projects: A System of Tripartite Responsibility (Fort
Lauderdale Statement, 2003)
 International Declaration on Human Genetic Data
(UNESCO, IBC 2003)
 European Society of Human Genetics: Data Storage
and DNA Banking for Biomedical Research (ESHG
2003)
 Universal Declaration on Bioethics and Human
Rights (UNESCO 2005)
 Additional Protocol to the Convention on Human
Rights and Biomedicine, concerning Biomedical
Research (Council of Europe 2005)
 Recommendation Rec (2006) 4 of the Committee of
Ministers to Member States on Research on Biological
Materials of Human Origin (Council of Europe 2006)
 OECD Principles and Guidelines for Access to
Research Data from Public Funding (OECD 2007)
 International Ethical Guidelines for Epidemiological
Studies (CIOMS, WHO 2008)
 2008 Best Practices for Repositories: Collection,
Storage, Retrieval and Distribution of Biological
Material for Research (ISBER 2008)
 Recommendations from the 2008 International
Summit on Proteomics Data Release and Sharing
Policy (Amsterdam Principles, 2008)
 Guidelines for Human Biobanks and Genetic
Research Databases (OECD 2008, 2009)
 Toronto Statement on Prepublication Data Sharing
(2009)
 Joint Statement by Funders of Health Research
(2011)
 Responsible Conduct in the Global Research
Enterprise: A Policy Report (InterAcademy Council
2012)
 Declaration of Helsinki (WMA 2013)
 Guidelines governing the Protection of Privacy and
Transborder Flows of Personal Data (OECD 2013)Authors’ contributions
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